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ThepresentstudyevaluatedtheameliorativeeﬀectofvitaminConalterationinthyroidhormonesinducedbylow-dosesubchronic
coadministration of chlorpyrifos (CPF) and lead (Pb). Forty Wistar rats were divided into 4 groups of 10 animals each.
Groups I and II were administered soya oil (2mL/kg) and vitamin C (100mg/kg), respectively. Group III was coadministered
CPF (4.25mg/kg ∼1/20th LD50) and Pb (250mg/kg ∼1/20th LD50), respectively. Group IV was pretreated with vitamin C
(100mg/kg) and then coadministered with CPF (4.25mg/kg) and Pb (250mg/kg), 30min later. The regimens were administered
by gavage for a period of 9 weeks. The marginal decrease in serum triiodothyronine and thyroxine and the signiﬁcant increase
in the concentrations of thyroid stimulating hormone and malonaldehyde in the group coadministered with CPF and Pb were
ameliorated by vitamin C partly due to its antioxidant properties.
1.Introduction
Man and animals are exposed to a “soup” of chemical con-
taminants in the environment, which directly or indirectly
aﬀect their health and well-being. Pesticides and heavy
metals are the most common environmental contaminants
because of their respective widespread use in agriculture
and industries. Hitherto, most studies on these chemical
contaminantshavecenteredontheexaminationofonesingle
agent and therefore, current understanding of the toxicity of
many environmental toxicants/pollutants is based primarily
on toxicitystudiesperformed on laboratory animals exposed
to a single toxic agent [1, 2]. However, the environment is
heavily contaminated with many chemicals, which interact
witheachotherinsuchawaythatmodifytheirtoxicresponse
in humans and animals.
Organophosphate (OP) compounds are the most widely
used insecticides accounting for 50% of global insecticidal
use [3] while Pb is the most widespread heavy metal con-
taminants with wide applications [4]. Occupational and
environmental Pb exposure continues to be among the most
signiﬁcant public health problems [4–7]. Due to their per-
sistent nature in the environment and their toxicodynamics,
CPF and Pb have resulted in deleterious eﬀects in man and
animals [8].
The toxicity of Pb remains a matter of public health
concern [9] due to its pervasiveness in the environment and
the awareness about its toxic eﬀects [10]a te x p o s u r el e v e l s
lower than what was previously considered harmful [11].
Reproductive consequences of Pb exposure are widespread
[12], aﬀecting almost all aspects of reproduction [13]. Pb
induces decreased sperm count and motility and increased
morphological abnormalities in animals [14, 15]. CPF is one
of the most common insecticidal environmental contami-
nants [16, 17]. Despite restrictions placed on some of its
domestic uses by United States Environmental Protection
Agency (USEPA) in 2000, CPF is still widely used as
residues have been detected in citrus fruits in some parts of
the world [18]. Adverse reproductive outcomes have been
observed following CPF poisoning [16, 17, 19–21]. The2 Journal of Thyroid Research
adverse reproductive health outcomes even as a result of
environmental exposure to CPF have been partly linked to
hypothyroidism [17].Furthermore, otherstudieshavefound
hypothyroidism in both CPF [17, 22–24]a n dP b[ 25–28]
poisonings. Since adequate thyroidal function is essential for
eﬀective and optimal reproductive performance, therefore,
measures aimed at mitigating the thyroid dysfunction insti-
gated by exposure to low-dose environmental contaminants
are pertinent.
Although the mechanisms of toxicity of the two agents
diﬀer, oxidative stress is a common feature in CPF [29–
33]a n dP b[ 34–36] poisoning. However, ascorbic acid has
shown tremendous promise in mitigating toxicity evoked
by CPF [31, 33, 37, 38]a n dP b[ 28, 39]. Therefore, the
present paper was aimed at evaluating the eﬀect of low dose
subchronicexposuretoCPFandPbonthyroidfunctions, the
role of thyroidal lipoperoxidation, and ameliorative eﬀect of
vitamin C in Wistar rats.
2.MaterialandMethods
2.1. Experimental Animals. Forty 6-week-old adult male
Wistar rats were obtained from the Animal House of the
Department of Veterinary Physiology and Pharmacology,
Ahmadu Bello University, Zaria, Nigeria. The rats were fed
on standard rat pellets, and water was provided ad libitum.
The experiment was performed in compliance with the
National Institutes of Health Guide for Care and Use of
Laboratory Animals [40].
2.2. Chemicals. Commercial grade CPF (Termicot 20% EC,
Sabero Organics, Gujarat, India) was reconstituted in soya
oil to 10% solution, which was subsequently used for the
experiment. Analytical grade lead acetate (Kiran Light Labo-
ratories,Mumbai,India)usedforthestudywasreconstituted
into a 20% solution using distilled water. Commercial grade
vitaminC tablets(100mg/tablet;Emzor Pharmaceutical Ltd,
Nigeria, BN:618N) were dissolved in distilled water to 10%
solution just before daily administration.
2.3. Animal Treatments. Forty adult male Wistar rats were
divided into 4 groups of 10 animals per group. The rats
in group I (C/oil) were administered corn oil (2mL/kg),
while those in group II (VC) were administered vitamin
C (100mg/kg). Rats in group III (CPF) were coadminis-
tered CPF 4.25mg/kg, ∼1/20th LD50 [24] and lead acetate
225mg/kg, ∼1/20th LD50 [28], respectively. Rats in group
IV (VC + CPF + Pb) were pretreated with vitamin C,
and then coadministered with CPF (4.25mg/kg) and Pb
(225mg/kg),30minlater. These regimenswere administered
orally by gavage once daily for a period of 9 weeks. At
the end of the dosing period, the rats were sacriﬁced by
jugular venisection after light chloroform anesthesia. Serum
obtained from each blood sample was used to evaluate for
the concentrations of triodothyronine (T3), thyroxine (T4),
and thyroid stimulating hormone (TSH), while the thyroid
glandwasweighedandthenevaluatedforthemalonaldehyde
(MDA) concentration as an index of lipoperoxidation.
2.4. Evaluation of Concentrations of Triodothyronine—Thy-
roid Stimulating Hormone and Thyroxine. The concentra-
tions of T3,T 4, and TSH were assayed using enzyme-linked
immunosorbent assay (ELISA) kits (Microwell TSH, T3,T4
kits; Synthron Bioresearch, Inc, USA).
2.5. Eﬀect of Treatments on Thyroid Gland Lipoperoxidation.
The level of thiobarbituric acid reactive substance, mal-
onaldehyde (MDA) as an index of lipid peroxidation was
evaluated in the thyroid gland using the double heating
method of Draper and Hadley [41]. The principle of the
method was based on spectrophotometric measurement of
the color developed during reaction of thiobarbituric acid
(TBA) with malonaldehyde. The thyroid glands from each
animal inallthegroupswereweighedandthenhomogenized
in a known volume of ice-cold phosphate buﬀer to obtain
a 10% homogenate, which was centrifuged at 2000g for
10min to obtain the supernatant. The supernatant was then
used to assess the level of protein and MDA in the sample.
The assessment of MDA concentration in the supernatant
of thyroid gland homogenate was performed thus; 2.5mL
of 100g/L trichloroacetic acid solution was added to 0.5mL
of the thyroid gland homogenate in a centrifuge tube and
placedina boilingwaterbathfor15min. Aftercoolingunder
tap water for 5min, the mixtures were then centrifuged at
1000g for 10min. 2mL of the supernatant was added to
1mL of 6.7g/L (0.67%) thiobarbituric acid (TBA) solution
in a test tube and placed in a boiling water (100◦C) bath
for 15min. The solution was cooled under tap water and
the absorbance was thereafter measured at 532nm using
a UV spectrophotometer (T80+UV/VIS Spectrometer PG
Instruments Ltd, UK).The concentrationof MDA calculated
by the absorbance coeﬃcient of MDA-TBA complex (1.56 ×
105 cm−1) and expressed as nmol/mg of tissue protein. The
protein concentration was determined using the method
described by Lowry et al. [42].
2.6. Statistical Analysis. Data obtained were expressed as
mean + SEM and then subjected to one-way analysis of vari-
ance followed by Tukey’spost hoc test using Graphpad prism
version 4.0. Values of P<. 05 were considered signiﬁcant.
3.Results
3.1. Eﬀect of Treatments on Serum Triiodothyronine Concen-
tration. The eﬀect of treatments on serum T3 level is shown
in Figure 1.T h e r ew a sn os i g n i ﬁ c a n td i ﬀerence in the serum
T3 level between the groups. However, the CPF + Pb group
had the lowest T3 concentration with its level decreasing by
14.3%,29%,and14.3%,respectively,relativetotheS/oil,VC,
and VC + CPF + Pb groups.
3.2. Eﬀect of Treatments on Serum Thyroxine Concentration.
There was no signiﬁcant (P>. 05) diﬀerence in the serum
T4 level between the groups. However, the lowest T4 level
was recorded in the CPF + Pb group as its level decreased
by 0.6%, 32%, and 26% compared to S/oil, VC, and VC +
CPF + Pb groups, respectively (Figure 2).Journal of Thyroid Research 3




























Figure 1: Eﬀect of subchronic coexposure of soya oil (S/oil) and
vitaminC(VC)and/orcombinationofchlorpyrifos (CPF) andlead
(Pb) on triodothyronine concentration in Wistar rats.
































Figure 2: Eﬀect of subchronic coexposure of soya oil (S/oil) and
vitaminC(VC)and/orcombinationofchlorpyrifos (CPF) andlead
(Pb) on serum thyroxine concentration in Wistar rats.
3.3. Eﬀect of Treatments on Serum Thyroid Stimulating
Hormone Concentration. The eﬀect of treatments on TSH
concentration is shown in Figure 3.T h e r ew a sas i g n i ﬁ c a n t
(P<. 01) increase in the TSH concentration in CPF + Pb
group compared to S/oil group. The TSH concentration in
the VC + CPF + Pb group signiﬁcantly (P<. 05) increased
compared to S/oil group. There was no signiﬁcant (P>. 05)
change in the TSH concentration in the VC group compared
to S/oil, CPF + Pb, or VC + CPF + Pb group.
3.4. Eﬀect of Treatments on Thyroid Malondialdehyde Con-
centration. The eﬀect of treatments on thyroidal MDA
concentration of various groups is shown in Figure 4.
There was a signiﬁcant (P<. 01) increase in the MDA
c o n c e n t r a t i o ni nt h eC P F+P bg r o u pw h e nc o m p a r e dt o
S/oil, VC, or VC + CPF group. The MDA concentration
signiﬁcantly (P<. 0 1 )i n cr e a s e di nth eV C+CP F+P bgr o u p
compared to VC group.
3.5. Eﬀect of Treatments on the Weight of Thyroid Gland. The
eﬀect of treatments on the weight of thyroid gland is shown
in Figure 5. There was no signiﬁcant change (P>. 05) in the
b
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Figure 3: Eﬀect of subchronic coexposure of soya oil (S/oil) and
vitaminC (VC)and/orcombinationofchlorpyrifos (CPF) andlead
(Pb) on thyroid stimulating hormone concentration in Wistar rats.
aP<. 01 versus S/oil group, bP<. 05 versus S/oil group.
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Figure 4: Eﬀect of subchronic coexposure of soya oil (S/oil) and
vitaminC (VC)and/orcombinationofchlorpyrifos (CPF) andlead
(Pb) onthyroid malonaldehyde concentrationinWistar rats. abcP<
.01 versus S/oil, VC and VC + CPF + Pb groups, respectively; dP<
.01 versus VC.
weight of the thyroid gland in between the groups. However,
the thyroid weight was higher in the CPF group by 11.4%,
8%, and 7.2% relative to C/oil, VC, and VC + CPF groups,
respectively.
4.Discussion
Low-dose subchronic coadministration of CPF and Pb
mimicking environmental exposure, which did not cause
any apparent systemic toxicity, has been shown to cause
a nonsigniﬁcant decrease in the serum level of T3 and
T4 in the present study. Although, the alteration in the
concentration of thyroid hormone was not signiﬁcant, the
fact that these very low doses of CPF and Pb did cause some
level of hormonal changes should not be ignored as it may
indicate ongoing subclinical metabolic alterations within
the system. CPF has been shown to induce hypothyroidism
in ewes [22]a n dr a t s[ 23, 24, 43]. Zaidi et al. [44]
recorded hypothyroidism in the serum of some pesticide
formulators. Similarly, Meeker et al. [17]d e m o n s t r a t e da n4 Journal of Thyroid Research



































Figure 5: Eﬀect of subchronic coexposure of soya oil (S/oil) and
vitaminC(VC),and/orcombinationofchlorpyrifos(CPF)andlead
(Pb) on the weight of thyroid gland in Wistar rats.
inverse association between urinary concentration of CPF
metabolites, 3,5,6-trichloro-2-pyridinol and T4 level and a
positive association with TSH. In the same vein, hypothy-
roidism has been associated with Pb [45, 46] poisoning.
Perhaps the reason why the coadministration of CPF and Pb
did not result in signiﬁcant alteration in thyroid hormone
concentrations may be due to the very low doses of the two
chemicals used.
Although T3 is a poor indicator of subclinical or overt
hypothyroidism, the marginal decrease in serum T3 level
observed in the group subchronically coadministered with
CPF and Pb may be due to the low T4 level observed in
the group rather than a decrease synthesis. This is because
T4 have to be converted to T3 for the biological eﬀect of
the hormone to be manifested. In addition, the relative low
T3 level may also be due to deﬁciency in the synthesis of
5 -deiodionase, an enzyme responsible for the conversion
of T4 to the more metabolically active T3.I n d e e d ,P bh a s
been shown to inhibit the activity of type-I iodothyronine
5 -monodeiodinase (5 -D) activity [45]. CPF has been
suggested to diﬀerentially aﬀect peripheral deiodination
[23]. The low 5 -deioodinase activity may have been due
to pathological changes in the organs responsible for its
synthesis by both CPF and Pb.
The marginal decrease in the level of T4 observed in
the group coadministered with CPF and Pb may be due to
some level of damage to the thyroid acinar probably due to
oxidative stress induction by both CPF [23, 24, 43, 44]a n d
Pb [47, 48]. Although, the present study did not evaluate
histological changes in the thyroid glands, Pb on its own
has beenshown tocause hypothyroidism eitherby inhibiting
iodine uptake [25, 26] and to cause functional impairment
of the pituitary—thyroid axis [27].
Some level of improvement in the concentration of
T3 and T4 in group pretreated with vitamin C probably
underscorestheroleofoxidativestressinthyroiddysfunction
evoked by coadministration of CPF and Pb as indicated
by low lipoperoxidative changes in the VC + CPF + Pb
group. The vitamin C having protected the thyroid acinar
from oxidative damage may have aided in restoring thyroid
hormones’ synthetic function. Apart from its antioxidant
properties, some other nonantioxidant activity of vitamin
C may have complemented the restoration of thyroidal
function. For example, vitamin C has been demonstrated to
aid the synthesis of paraoxonase, an important esterase that
aids in the detoxiﬁcation of OPs [49].
The signiﬁcant increase in the TSH concentration in
the group coadministered with CPF and Pb may be due
to the attempt by the body to stimulate the thyroid gland
to increase the synthesis and elaboration of T4 in order to
compensate for the apparent deﬁcit in the system. CPF-
induced increase in TSH concentration has been recorded
in humans [17, 44] and laboratory animal models [23, 24].
The low T4 concentration in the CPF + Pb group may have
stimulatedthehypothalamicneuronstosecretethyrotrophin
releasinghormone(TRH)leadingtoincreasedstimulationof
TSH synthesis [50]. The apparent normalization of the TSH
concentration in group pretreated with vitamin C correlates
positively with the marginal improvement in T4 and T3
c o n c e n t r a t i o ni nt h eg r o u p .
The study revealed a signiﬁcant increase in the MDA
concentration in the thyroid gland of CPF + Pb group as
compared to other groups. This increased MDA concentra-
tion is indicative of oxidative damage to the thyroid gland.
This may be attributed to the high metabolic rate, high level
of free radicals accumulation, and low level of endogenous
antioxidant in the thyroid gland. Oxidative stress induction
is one of the molecular mechanism of CPF [31–33]a n d
Pb [28, 34] poisoning. Oxidative stress, characterized by
an elevation in the steady-state concentration of reactive
oxygen species (ROS), has been implicated in a wide range
of biological and pathological conditions [51]. Thyroid
hormones are associated withthe oxidativeand antioxidative
status of the organism [52]. Because of its role in oxidative
metabolism, increase concentration of ROS is formed in
the thyroid glands. However, the combination of CPF and
Pb was shown to have exacerbated the ROS induction
perhaps due to their direct interaction with the thyroid
acinar. Lipid peroxidation inactivates cell constituents by
oxidation or causes oxidative stress by undergoing radical
chain reaction, ultimately leading to loss of membrane
integrity [53]. Similarly, the increased MDA concentration
mayhavebeenexacerbatedduetoimpairmentofantioxidant
enzymes that have beenreported in hypothyroidism [54]. Pb
onitsowninduceslipoperoxidationbyinhibitingtheactivity
of δ-aminolevulinic acid dehydrase leading to accumulation
of its substrate δ-aminolevulinic acid, which rapidly oxidize
to generate free radicals as superoxide ion, hydroxyl radical,
and hydrogen peroxide [7].
Pretreatment with vitamin C has been shown by the
present study to ameliorate the lipoperoxidative changes
induced by subchronic administration of coadministration
of CPF and Pb. This was apparently due to antioxidant
property of the vitamin. The antioxidant properties of
vitamin C have been demonstrated in numerous studies
involving CPF-induced lipoperoxidation [31, 33, 37, 38].
The weight of the thyroid was marginally higher in the
CPF + Pb group than any of the other three groups. TheJournal of Thyroid Research 5
reason for the relatively higher weight in the CPF + Pb group
maybe relatedtothe signiﬁcantly higherTSHconcentration,
which may have partly stimulated the proliferation of the
thyroid follicular cell [55], apparently to compensate for
the marginal decrease in thyroid hormones. Although, the
weight of the thyroid gland was marginally higher in the
group pretreated with vitamin C than those of C/oil and VC
groups, the fact that it was lower compared to CPF + Pb
groupdemonstratesapparentrestoration ofthe weightofthe
thyroid gland by vitamin C.
5.Conclusion
Subchronic coadministration ofCPF and Pb has been shown
by the present study to marginally decrease thyroid hor-
mones concentration, increase TSH concentration and thy-
roid lipoperoxidation, and marginally increase the weight
of the thyroid gland. The alterations in these thyroid gland
parameters were ameliorated by pretreatment with vitamin
C apparently due to its antioxidant properties.
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